These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 14632812

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Safety and prolonged efficacy of Botulin Toxin A in primary hyperhidrosis.
    D'Epiro S, Macaluso L, Salvi M, Luci C, Mattozzi C, Marzocca F, Salvo V, Scarnò M, Calvieri S, Richetta AG.
    Clin Ter; 2014; 165(6):e395-400. PubMed ID: 25524193
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. DYSBOT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A--Dysport and Botox--assuming a ratio of 4:1.
    Sampaio C, Ferreira JJ, Simões F, Rosas MJ, Magalhães M, Correia AP, Bastos-Lima A, Martins R, Castro-Caldas A.
    Mov Disord; 1997 Nov; 12(6):1013-8. PubMed ID: 9399229
    [Abstract] [Full Text] [Related]

  • 27. Treatment of plantar hyperhidrosis with botulinum toxin type A.
    Vadoud-Seyedi J.
    Int J Dermatol; 2004 Dec; 43(12):969-71. PubMed ID: 15569036
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The place of botulinum toxin type A in the treatment of focal hyperhidrosis.
    Lowe N, Campanati A, Bodokh I, Cliff S, Jaen P, Kreyden O, Naumann M, Offidani A, Vadoud J, Hamm H.
    Br J Dermatol; 2004 Dec; 151(6):1115-22. PubMed ID: 15606505
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Botulinum toxin A (Botox) and sweating-dose efficacy and comparison to other BoNT preparations.
    Schlereth T, Mouka I, Eisenbarth G, Winterholler M, Birklein F.
    Auton Neurosci; 2005 Feb 07; 117(2):120-6. PubMed ID: 15664565
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Focal hyperhidrosis: effective treatment with intracutaneous botulinum toxin.
    Naumann M, Hofmann U, Bergmann I, Hamm H, Toyka KV, Reiners K.
    Arch Dermatol; 1998 Mar 07; 134(3):301-4. PubMed ID: 9521028
    [Abstract] [Full Text] [Related]

  • 35. Treatment of axillary hyperhidrosis with botulinum-A toxin.
    Salmanpoor R, Rahmanian MJ.
    Int J Dermatol; 2002 Jul 07; 41(7):428-30. PubMed ID: 12121560
    [Abstract] [Full Text] [Related]

  • 36. Botulinum toxin therapy for palmar hyperhidrosis.
    Shelley WB, Talanin NY, Shelley ED.
    J Am Acad Dermatol; 1998 Feb 07; 38(2 Pt 1):227-9. PubMed ID: 9486678
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Pharmacokinetic properties of different formulations of botulinum neurotoxin type A.
    Wohlfarth K, Kampe K, Bigalke H.
    Mov Disord; 2004 Mar 07; 19 Suppl 8():S65-7. PubMed ID: 15027057
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.